WO2002009653A1 - Bandes cosmetiques adhesives - Google Patents

Bandes cosmetiques adhesives Download PDF

Info

Publication number
WO2002009653A1
WO2002009653A1 PCT/GB2001/003418 GB0103418W WO0209653A1 WO 2002009653 A1 WO2002009653 A1 WO 2002009653A1 GB 0103418 W GB0103418 W GB 0103418W WO 0209653 A1 WO0209653 A1 WO 0209653A1
Authority
WO
WIPO (PCT)
Prior art keywords
adhesive
cross
skin
preferred
patches
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/003418
Other languages
English (en)
Inventor
Fumio Kamityama
Ying-Shu Quan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Pharmaceutical Development Ltd
Original Assignee
Kyowa Kirin Pharmaceutical Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Kirin Pharmaceutical Development Ltd filed Critical Kyowa Kirin Pharmaceutical Development Ltd
Priority to AU2001272679A priority Critical patent/AU2001272679A1/en
Publication of WO2002009653A1 publication Critical patent/WO2002009653A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Definitions

  • the present invention relates to adhesive substrates, particularly patches and strips, for the delivery of cosmetics, the adhesive being a cohesive bioadhesive comprising both adhesive polymer and plasticiser.
  • bioadhesives exist, including medical tape and dermal patches, for example. Methods of manufacture of these products are well advanced, but the nature of the adhesive remains a problem.
  • bioadhesive If the bioadhesive is too weak, then the patch or tape will tend to come away from the skin before it should. This has led to bioadhesives being developed which have merely been adapted so as not to be too strong to be painful, and not so weak as to be relatively useless.
  • EP-A-450986 discloses an acrylic adhesive plasticised with isopropyl myristate (IPM) and which also contains nitroglycerine, which can further serve as a plasticiser.
  • IPM isopropyl myristate
  • cross-linking was effected with aerosil silica.
  • the problem with such cross-linking is the technical difficulty involved in sufficiently finely dividing the aerosil silica and incorporating it uniformly throughout the adhesive. Such cross-linking would not be generally practical.
  • US-A-5298258 seeks to solve the problems noted above, and discloses acrylic adhesives containing substantial amounts of plasticisers.
  • Various methods for cross-linking the adhesive are mentioned, including irradiation and exposure to UV, but chemical cross-linking with a metal alcoholate, metal chelate or trifunctional isocyanate is preferred.
  • the cross-linking of such an adhesive requires the presence of active hydrogen, generally in the form of a carboxyl or hydroxyl group, typically provided by a co-monomer having the required functionality.
  • WO 99/02141 discloses block copolymers wherein the soft segments are cross- linked, these copolymers being suitable for use as drug-retaining bioadhesives in dermal patches. These adhesives tend to suffer a loss of cohesion, however, when a plasticiser is incorporated.
  • EP-A-953348 to L'Oreal discloses skin patches for cosmetics wherein the .- adhesive should be soft.
  • EP-A-450986 (Sekisui) discloses nitroglycerine patches which are intended to be non-irritant.
  • WO00/45785 (Acutek), an intermediate document, discloses cosmetic patches wherein the adhesive contains an oil as a softener.
  • WO99/26572 discloses anti-wrinkle patches wherein a pressure sensitive adhesive comprises glycerine and a polydiorganosiloxane adhesion-adjusting agent.
  • FR-A-2735024 discloses cosmetic patches and US-A-5298258 (supra, Nitto Denko) discloses a cross-linked acrylic adhesive whose properties are modified by a plasticiser, but no further cross-linking is disclosed.
  • the present invention provides dermaliy attachable dispensing means comprising a substrate upon which is disposed an adhesive material, the adhesive material comprising a cross-linked, adhesive polymer and a plasticiser therefor, ketone groups in the adhesive being cross-linked by a polyamine cross-linking agent, the adhesive comprising plasticiser sufficient to reduce discomfort on dermal detachment, characterised in that the substance to be dispensed comprises a cosmetic agent.
  • the dispensing means of the invention is attachable to the hair, skin, or epidermis, of the intended user. Attachment to the mucosae, such as the inside of the mouth, is also considered as skin herein, and provides an embodiment of the invention. Attachment to hair is not especially preferred but is encompassed herein, there being little requirement for therapeutic acceptability in such uses. Indeed, in such cases, the dispensing means may comprise a tape carrying bleach or hair colourant, for example.
  • the dispensing means of the invention is intended for secure attachment for a period of hours, with substantially pain-free, or painless, removal at the end of the period of use.
  • the adhesives used in the dispensing means, or patches, of the present invention are advantageous in that they provide secure attachment, low to virtually no irritation, and can be removed substantially or completely painlessly. In addition, this is generally and preferably achieved without leaving a residue on the user's skin.
  • the dispensing means of the present invention will often take the form of a patch or other adhesive dressing or cosmetic vehicle.
  • patch is used interchangeably herein with “dispensing means” and extends equally to other forms of dispensing means, such as tape, unless otherwise apparent.
  • the substrate may be any that is suitable to carry the adhesive and permit attachment to the skin of the user.
  • a preferred substrate is flexible and preferably thin, for comfort, although it may comprise a rigid, shaped support for a specific region of the body, for example.
  • the substrate may simply comprise a flexible web on which the adhesive is disposed.
  • the substrate may comprise a backing and a reservoir for the cosmetic agent attached thereto.
  • the reservoir may comprise any adsorbent or absorbent substance capable of carrying the cosmetic agent chosen, and is preferably adhered to the backing, such as by adhesion, the cosmetic agent generally being loaded after adhesion.
  • the adhesive of the present invention may then be layered around or over the reservoir, although it is preferred to layer the adhesive over the reservoir for ease of manufacture.
  • the adhesives used in the patches of the invention are capable of high loading of cosmetic agents, so that any cosmetic agent in the reservoir passes through the adhesive onto the skin once in situ.
  • the adhesives used in the present invention are capable of high levels of loading of cosmetic agent, so that it is not necessary to provide a separate reservoir, the adhesive serving the purpose. Suitable quantities of the adhesive may be selected to carry the cosmetic, and such matrix patches are preferred embodiments of the present invention.
  • the adhesive polymer comprises a minority of monomeric sub-units exhibiting free keto groups with little tendency to enolisation after polymerisation. At least some of these groups are cross-linked with a polyamine, two free amine groups on the cross-linking agent reacting with keto groups on separate monomers to effect a cross-link.
  • free amine groups is meant that there is at least one hydrogen substituent on the nitrogen.
  • Suitable plasticisers are illustrated below, but may be any that is suitable for use in topical administration. Such considerations apply to any of the components of the patches of the invention likely to come into prolonged contact with the skin of a user.
  • the plasticiser may be one and the same as the cosmetic agent, where the agent is suitable for such use. In such a case, it will be appreciated that the amount of cosmetic agent will be in excess of that otherwise required for simple cosmetic application, in order to provide the qualities of the adhesive. Where the plasticiser is not the same as the cosmetic, then it should be miscible with the adhesive. In this respect, “miscible” indicates that the plasticiser, once mixed with the adhesive and after cross-linking, exhibits little or no tendency to seep out of the patch, with time. Naturally occurring organic substances are preferred, while many mineral oils are unsuitable. Examples of preferred plasticisers are given hereinbelow.
  • plasticiser The amount of plasticiser required is what is sufficient to reduce discomfort on dermal detachment, that is, when the patch is removed from the skin of the user the plasticiser lends those qualities of ready and painless removal. If there is too little plasticiser, then irritation and redness can result, and removal made painful. Suitable levels are readily determined by those skilled in the art but, for guidance, are generally between 17% and 200% by weight (w/w). More preferred ranges are illustrated and discussed hereinbelow.
  • the adhesive used in the present invention is preferably a bioadhesive, in that there is little or no appreciable long-term toxicity.
  • Other adhesives removable without pain have far less adhesive qualities and have poor cohesion, often leaving substantial amounts of adhesive on the skin, requiring an alcoholic swab for removal of the residue.
  • the adhesives of the present invention are contact adhesives, in that the patches of the invention can be prepared and stored on a release layer for long periods, and then simply applied to the skin of the user where they will adhere as required without any further preparation or wetting, for example.
  • an adhesive of the invention which is loaded with a cosmetic agent.
  • the adhesive may be provided between two sheets of release layer and applied as required. Such substance may be useful where it is desired to apply a decoration or other object or material over the patch area other than a standard backing.
  • loaded is meant that the adhesive has been impregnated with the agent, or is otherwise carrying the agent. It is not necessary that the levels of agent be at saturation.
  • a patch or tape comprising a cosmetic agent for delivery to the skin and an adhesive material suitable for use as a bioadhesive, the adhesive material comprising an adhesive polymer and a plasticiser therefor, wherein the adhesive is cross-linked, characterised in that the adhesive comprises ketone groups cross-linked by a polyamine cross-linking agent.
  • the dermal dispensing means is generally any that is capable of delivering the cosmetic agent onto, into, or through, any or all layers of the skin.
  • most cosmetic agents suitable to be administered by delivery in accordance with the present invention are for administration into or onto the dermis and epidermis, especially the epidermis, including the stratum corneum.
  • the dispensing means may take any suitable form, provided that the adhesive is used for adhesion to the skin.
  • Particularly suitable forms are tapes and patches, especially dermal delivery patches, but other forms, such as plasters and bandages, for example, are also envisaged.
  • Simple tapes, for example may to be cut to desired shapes and sizes for application, the adhesives of the invention being capable of holding substantial amounts of the agent.
  • specific forms of dispensing means such as tapes and patches, are referred to herein, such reference includes reference to other forms of dispensing means, unless otherwise apparent.
  • the means of the present invention comprises a backing layer bearing the adhesive which, in turn, comprises the cosmetic agent.
  • the exposed face of the adhesive will generally be covered with a readily removable protective layer, such as a paper, plastics or a metal foil.
  • Such adhesives of the present invention in combination with a cosmetic agent allows the agent to be delivered to the skin via a matrix patch, for example, without causing skin trauma when the patch is removed. This is especially important in cosmetic applications, for example, to the face. Such patches will often be applied daily, for example, and it is important that there be minimum irritation and skin surface removal, and minimal adhesive residue on removal.
  • an adhesive as described herein allows optimum delivery of the cosmetic agent to the skin.
  • the presence of the plasticiser in the adhesive allows the adhesive to closely follow the contours of the skin, such that the maximum surface area of the dermal dispensing means is in contact with the skin.
  • the invention provides a method of cosmetic treatment, comprising applying a dispensing means of the invention to skin or mucosae that it is desired to treat.
  • Cosmetic agents used in the patches of the present invention are any agents which generally serve to enhance appearance, especially of the skin or hair, and may generally function so as to improve skin tone, or by reducing or reversing skin wrinkles, or by masking or reducing skin blemishes, for example.
  • Preferred agents are those which serve to reduce or reverse the effects of ageing upon the skin, such as wrinkles and age- or liver-spots, especially facial skin, or which, at least, appear to do so, either temporarily or permanently.
  • Other suitable cosmetic effects are well known in the art.
  • Examples of preferred cosmetic agents include vitamin C, vitamin D2, vitamin D3, vitamin A, vitamin E, natural and synthetic ceramides, alpha hydroxyacids, retinoids, agents changing (darkening or lightening) skin pigmentation, tyrosine, essential fatty acids, tocotrienols, herb extracts, phospholipids, squalene, urea, olive oil, lauric acid, isopropyl myristate, cetyl alcohol, essential oils such as tea tree oil, peppermint oil, rosemary oil, avocado oil, almond oil, palm kernel oil, babassu oil, hemp seed oil, mango seed oil, brazil nut oil, grape seed oil, jojoba oil, sandlewood oil, carrot oil, peach kernel oil, wheat germ oil, macadamia nut oil, lavender oil and eucalyptus oil, plant and herb extracts such as Aloe vera, elderflower, cucumber, witch hazel, green tea, seaweed, algae, watermelon, hawthorn flower,
  • patches and tapes of the invention may comprise more than one cosmetic agent, if so desired, in which case they are most preferably compatible.
  • the cosmetic agents such as those exemplified, may also be used in the form of salts or esters, or other derivatives or analogues.
  • vitamin E acetate and vitamin A palmitate are preferred compounds for use in the present invention.
  • hydrophilic compounds it is generally preferred to provide these as derivatives, where they are to be incorporated directly into the adhesive.
  • vitamin C mono- and di- palmitate are preferred for use in the present invention.
  • hydrophilic compound may be used in combination with additional delivery systems such as liposomes, for example, to enhance delivery to and into the dermis and epidermis.
  • hydrophilic compounds may be ground to a fine powder and then mixed into the adhesive solution for delivery, or may be admixed with an amphiphilic agent such as a surfactant, for example a poloxamer such as P407 or PI 88, to assist in uptake by the adhesive.
  • a surfactant for example a poloxamer such as P407 or PI 88
  • the cosmetic agent be transdermally delivered.
  • Many agents act on the upper skin surface or penetrate only into the first few skin cell layers, such that all that is necessary is for the tape or patch to deliver the agent into or onto the skin surface.
  • patches and tapes of the invention generally deliver to a localised area of the skin. If it is desired to enhance uptake in the skin, then enhancers, such as are well known in the art, may be used.
  • the cosmetic agent may be present in any suitable concentration in the patch, and is preferably comprised in the adhesive.
  • the concentration may be any that is suitable, generally over very wide ranges, and is preferably present in a concentration of 0.001-100% by weight of the adhesive, more preferably 0.1-70% by weight of adhesive.
  • the lower ranges may be appropriate for highly active compounds, such as tretinoin, for example, while the higher ranges may be appropriate for such compounds as vitamin E and its derivatives. Similar considerations apply to situations where other means are used for cosmetic agent retention.
  • suitable concentrations will depend upon the nature of the cosmetic agent used and the intended effect, so that suitable concentrations will be readily apparent to those skilled in the art.
  • the cosmetic agent may act as a plasticiser.
  • the amount of plasticiser may be reduced, or even eliminated altogether, and the amount of cosmetic agent increased above 30% by weight, for example, of the adhesive. Suitable adjustments to the proportions of plasticiser and cosmetic agent are readily determined by those skilled in the art.
  • vitamin E particularly the acetate, for example, can act as a plasticiser for the adhesive of the present invention.
  • it has also surprisingly been shown to act to enhance the adhesive strength of the adhesive component of the present invention.
  • vitamin E serves to increase adhesive strength, so that less cross-linking is needed in the adhesives of the invention, and can enable a greater range of useful adhesives to be prepared.
  • the amount of cosmetic agent used will vary widely according to the effect it is intended to have, where it is intended for use, and the nature of the agent, as well as its solubility or other uptake characteristics in the adhesive. Such considerations are moot where the agent is borne in reservoir patch. In matrix patches, however and for guidance, the amount of cosmetic agent may be anywhere from about 1% to about 30% by weight, where the agent does not also serve as plasticiser. More preferred are concentrations between 5% and 25%, especially 10%) and 20% w/w.
  • the adhesive materials used in the present invention have been found to possess good water vapour permeabilities, which allows the skin to breathe when the tape or patch is in place, especially if the substrate is also breathable, which is preferred.
  • the lack of any necessary reactive groups in the adhesive is useful for the stability of active agents, and also in providing certain sorts of patch that could not previously be made, as the adhesives of the invention are generally susceptible to very little interaction with other materials.
  • polymer is used generically herein to relate to polymers, copolymers and mixtures thereof.
  • the polymer should be a synthetic polymer, in order to be able to provide adequate quality control and predictability of results. It is also advantageous to use synthetic polymers, as they can be controlled to contain desired side-groups, as necessary.
  • the adhesive polymer, or a substantial component thereof has at least one ketone group which is able to react with a polyamine.
  • Ketone groups are capable of tautomerisation, where there is an equilibrium between the ketone and the corresponding enol compound. This equilibrium is generally in favour of the ketone.
  • the ketone-containing polymer should have at least one ketone group with little or substantially no tendency to enolisation.
  • the ketone group should not be part of a larger functionality, and it is particularly the case that the ketone group should not be part of a carboxyl group or any derivative thereof, such as an esteric linkage or amide group, although it may be linked to or adjacent such a group. It is also strongly preferred that the ketone group should not be part of an aldehyde group.
  • the cross-linking reaction takes place between the keto form of the carbonyl group and the amine group of the cross-linking agent. It has been found that, if the ketone group is not stable in the keto form, then it reacts only poorly, if at all, with the cross-linking agent.
  • Preferred compounds are those- in which the keto form is at least 100 fold more stable than the enol form, preferably more stable by a factor of 10 4 , most preferably more stable by a factor of 10 6 or greater.
  • the equilibrium constant K (enol keto) when measured in water, is less than 10 "2 , more preferably less than 10 "4 , and most preferably less than 10 "6 , or even smaller. In this way, the equilibrium is strongly biased in favour of the keto form. Other factors aside, the more strongly biased the equilibrium toward the ketone group, the better.
  • Block copolymers are useful in the present invention.
  • Suitable block copolymers consist of a mixture of 'hard' (A) and 'soft' (B) segments, which may be combined in an A-B-A or (A-B) n type structure (c.f Block Copolymers: Overview and Critical Survey, Noshay and McGrath, 1977). Association of the hard segments is thought to provide a degree of physical cross-linking, which improves the cohesive properties of the adhesive.
  • Acrylic block copolymers, comprising soft and hard segments, having a degree of chemical cross-linking between the soft segments, are preferred.
  • the term 'block copolymer' refers to a macromolecule comprised of two, or more, chemically dissimilar polymer structures, terminally connected (Noshay and McGrath, supra). These dissimilar polymer structures, sections or segments, represent the 'blocks' of the block copolymer, the A and B segments comprising the chemically distinct polymer segments of the block copolymer. In the present invention, the A-B-A structure is preferred.
  • the adhesive agent used in the invention possesses a minimum number of functionalities having active hydrogen, in order to avoid undesirable reactions/interactions, such as with any active agent that it is desired to incorporate into the bioadhesive material. It will be appreciated that this is only a preferred restriction, and that any adhesive may be tailored by one skilled in the art to suit individual requirements. For example, it may be desirable to incorporate certain active groups into the adhesive in order to encourage uptake of a hydrophilic cosmetic agent, for example. However, limiting such functionalities generally helps to reduce irritation and, so, is preferred.
  • the substance having active agent retention properties is taken herein as being a substance capable of absorbing or adsorbing active agent.
  • absorbance and/or adsorbance should be at least partially reversible.
  • Tapes employing the adhesives of the invention exhibit good adhesion and cohesion, and release freely from the subject without painful exfoliation. It may also be beneficial for a tape of the present invention to carry such additional agents as antimicrobial agents, although adhesives of the invention, especially those comprising IPM as plasticiser, exhibit antimicrobial properties.
  • Preferred adhesives for use in the present invention are those which, in tests, can be applied to newspaper and readily removed therefrom without tearing the paper. Particularly preferred are those adhesives which can be removed from, and reapplied to, newspaper repeatedly, without losing adhesion or damaging the paper. Tapes having such properties are particularly useful, and are preferred embodiments of the present invention.
  • impermeable backings which may be used for dermal patches include films or sheets of polyolefins, polyesters, polyurethanes, polyvinyl alcohols, polyvinyl chlorides, polyvinylidene chloride, polyamides, ethylene-vinyl acetate copolymer (EVA), ethylene-ethylacrylate copolymer (EEA), vinyl acetate- vinyl chloride copolymer, cellulose acetate, ethyl cellulose, metal vapour deposited films or sheets thereof, rubber sheets or films, expanded synthetic resin sheets or films, non- woven fabrics, fabrics, knitted fabrics, paper and foils.
  • EVA ethylene-vinyl acetate copolymer
  • EAA ethylene-ethylacrylate copolymer
  • vinyl acetate- vinyl chloride copolymer cellulose acetate, ethyl cellulose, metal vapour deposited films or sheets thereof, rubber sheets or films, expanded synthetic resin sheets or films, non- woven fabrics, fabrics,
  • patches of the invention are breathable, and it is generally preferred that, while the backing material is strong and impermeable to the cosmetic agent, it should also be able to allow the passage of water vapour, at least in cosmetic applications.
  • water vapour permeability can be tempered by the requirement for impermeability to cosmetic agent.
  • Highly preferred adhesives for use with the present invention correspond to those disclosed in WO 99/02141 (supra), incorporated herein in its entirety. Where these adhesives do not already possess suitable ketone groups, these can readily be provided by the incorporation of a suitable monomer when preparing the polymer.
  • the adhesives of WO 99/02141 already possess good cohesion and adhesion, but addition of plasticiser compromises cohesion.
  • Cross-linking in accordance with the present invention enables the use of these adhesives with plasticiser, retaining their superior active agent retention properties and allowing control of the level of adhesion, while allowing painless and irritation-free removal of the patch.
  • Suitable alkyl acrylates and alkyl methacrylates include n-butyl acrylate, n-butyl methacrylate, hexyl acrylate, 2-ethylbutyl acrylate, isooctyl acrylate, 2 -ethylhexyl acrylate, 2-ethylhexyl methacrylate, decyl acrylate, decyl methacrylate, dodecyl acrylate, dodecyl methacrylate, tridecyl acrylate and tridecyl methacrylate, although other suitable acrylates and methacrylates will be readily apparent to those skilled in the art.
  • Acrylate block copolymers are suitably used in the present invention, and it is preferred that the acrylic block copolymer comprises at least 50% by weight of alkyl acrylate or alkyl methacrylate (co) polymer.
  • a polar monomer is copolymerised with an alkyl acrylate or alkyl methacrylate, in order to enhance the solubility of certain active agents.
  • Suitable such polar monomers include hydroxyethyl acrylate, hydroxypropyl acrylate, vinyl pyrrolidone, acrylamide, dimethylacrylamide, acrylonitrile, diacetone acrylamide and vinyl acetate.
  • Diacetone acrylamide or a combination of diacetone acrylamide and vinyl acetate, is useful in the present invention.
  • the diacetone acrylamide component enables more advantageous loading capabilities than vinyl acetate, but vinyl acetate enhances the rate of polymerisation, which is of commercial importance.
  • the levels of each monomer may be manipulated in such a way as to provide optimum retention and delivery properties.
  • diacetone acrylamide, or other polar monomer, such as hydroxyethyl methacrylate or vinyl acetate be present in no more than 50% w/w of the monomeric mix, as this can lead to reduced adhesion, for example.
  • good levels of cosmetic agent loading may be obtained with an excess of polar monomer.
  • the adhesive in the form of a copolymer.
  • the soft segment should be a copolymer. This not only has the advantage of giving a greater variety of polymers from which to select, but is also useful in providing the necessary ketone groups. Suitable monomers (comonomers) will be readily apparent to those skilled in the art and, essentially, are only otherwise limited to compounds which are copolymerisable in the system of choice and which provide the necessary ketone group.
  • Suitable ketone-providing monomers include aliphatic, olefinically unsaturated keto, preferably monoketo, compounds such as vinyl esters or allyl esters of aliphatic monobasic or dibasic acids containing a keto group and having a suitable number of carbon atoms, such as three to eight.
  • Suitable such acids include pyruvic acid, acetoacetic acid and levulinic acid, a suitable ester of such being the vinyl alcohol ester.
  • Suitable compounds include aliphatic amides substituted at the nitrogen by a vinyl or allyl group and other suitable monomers are the olefinically unsaturated ketones, such as vinylmethyl ketone and vinylethyl ketone.
  • a particularly preferred embodiment of the adhesive of the present invention uses a combination of butyl acrylate, 2-ethylhexyl acrylate and diacetone acrylamide, preferably in a ratio of about 4 : 4 : 3, either as the adhesive, or as the soft segment of the block copolymer, although other suitable preparations will be apparent to those skilled in the art.
  • ratios and percentages, as given herein, are by weight.
  • the present invention is not limited to specific plasticisers.
  • the only requirement for the plasticiser is that it be appropriate to the adhesive.
  • the adhesive For example, using the preferred adhesive noted above, naturally occurring castor oil has been found not to be appropriate, for example, as it leaks out of the adhesive, thereby preventing adhesion.
  • appropriate plasticisers are readily established by those skilled in the art.
  • a simple mixture of a plasticiser with the adhesive should provide a bioadhesive material, or material suitable for use as a bioadhesive (which expressions are used interchangeably herein), which does not separate, and which is adhesive, within the broad general ranges that have generally been noted. Too little plasticiser will generally result in an adhesive material which is too strong and insufficiently soft, while too much plasticiser will generally lead to disraption of the adhesive and permit insufficient adhesive quality.
  • the plasticiser may be used in an amount generally between about 20 and 200% of the adhesive, preferably between 20% and 150%, more preferably between about 30 and 120%, with about 100% generally providing good results. It will be appreciated, however, that different plasticisers will have different optima for different adhesives.
  • Plasticisers are generally liquids having high boiling points, and suitable examples include glycols, such as ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, polyethylene glycol and polypropylene glycol; fats and oils such as olive oil, jojoba oil, squalene and lanolin; organic solvents such as dimethyl decyl sulphoxide, methyl octyl sulphoxide, dimethyl sulphoxide, dimethylformamide, dimethylacetamide, dimethyllaurylamide, dodecyl pyrrolidone and isosorbitol; liquid surfactants; specific plasticisers such as diisopropyl adipate, phthalates and diethyl sebacate; hydrocarbons such as liquid paraffin; ethoxylated stearyl alcohol, glycerol esters, isopropyl myristate, isotridecyl myristate, ethyl laureate, N-methylpyr
  • Polyamines for use in the present invention should have two or more free amine groups to react with the ketone moiety of the adhesive.
  • hydrazine or hydrazine hydrate
  • the reactive amine should be bound directly to another nitrogen, or to another group providing the same or generally equivalent electronegativity as another nitrogen.
  • dihydrazine compounds and linked amine compounds are particularly preferred.
  • dialkylene triamines such as di-C 2-6 alkylene triamines wherein the alkylene groups are preferably the same length as each other, especially diethylene triamine [2-(2- aminoethylamine)ethylamine] or bishexamethylene triamine, but other suitable triamine and polyamine compounds will be readily apparent to those skilled in the art.
  • Dihydrazine compounds are especially preferably dihydrazides of polybasic organic acids, especially dicarboxylic acids.
  • aromatic dicarboxylic acids include phthalic acid, isophthalic acid and terephthalic acid, although others will be readily apparent to those skilled in the art.
  • dihydrazides are those of aliphatic saturated dicarboxylic acids, especially those having 2-10 carbon atoms, and dihydrazides of oxalic acid, adipic acid, and sebacic acids are suitable examples, while the diamino derivatives of medium chain alkanes are useful (C 5 _ 12 ), especially the straight chain alkanes, of which the hexane and dodecane derivatives are currently preferred, especially 1,6-diaminohexane and 1,12-diaminododecane. It will be apparent that polyhydrazides, as well as the dihydrazides, may also be employed.
  • the polyamines be used in an amount generally between about 0.05% and 2% of the adhesive, more specifically between about 0.3% and 1%, although individual polyamines will have different optima for different adhesives.
  • the quantity of the polyamine that is required may vary depending upon the amount of plasticiser that is used.
  • the amount of cross-linker that is added results in gelation of the adhesive, and is such that the adhesive cannot be subsequently dissolved by a solvent after cross-linking.
  • polymers suitable for use as the hard portion of the block copolymer possess glass transition temperatures above room temperature.
  • Suitable monomers for use in forming the hard segment polymer include styrene, ⁇ -methylstyrene, methyl methacrylate and vinyl pyrrolidone, although other suitable monomers will be readily apparent to those skilled in the art.
  • Polystyrene and polymethyl methacrylate have been found to be suitable for the present invention.
  • the hard portion of the block copolymer forms from 3-30% w/w of the total block copolymer, particularly preferably from 5-15% w/w.
  • Particularly suitable block copolymers have soft portions which have been at least partially chemically cross-linked prior to cross-linking with polyamine.
  • Such initial cross-linking may be effected by any suitable cross-linking agent.
  • the cross-linking agent be in the form of a monomer suitable for incorporation into the soft segment during polymerisation.
  • the cross- linking agent has two, or more, radically polymerisable groups, such as a vinyl group, per molecule of the monomer, at least one tending to remain unchanged during the initial polymerisation, thereby to permit cross-linking of the resulting block copolymer.
  • Suitable initial cross-linking agents for use in the present invention include divinylbenzene, methylene bis-acrylamide, ethylene glycol di(meth)acrylate, ethylene glycol tetra(meth)acrylate, propylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, or trimethylolpropane tri(meth)acrylate, although other suitable cross- linking agents will be readily apparent to those skilled in the art.
  • a preferred initial cross-linking agent is tetraethylene glycol dimethacrylate. It is preferred that the initial cross-linking agent comprises about 0.01-0.6% by weight of the block copolymer, with 0.1 -0.4% by weight being particularly preferred.
  • Block copolymer portions may be produced by any suitable method, such as step growth, anionic, cationic and free radical methods (Block Copolymers, supra). Free radical methods are generally preferred over other methods, such as anionic polymerisation, as the solvent and the monomer do not have to be purified.
  • Suitable initiators for polymerisation include polymeric peroxides with more than one peroxide moiety per molecule.
  • One suitable initiator has been found to be 'Perhexa MC (1,1 '-di-tertbutyl-peroxy-2-methyl cyclohexane, Nihon Yusi C.C). This compound contains two tertiary butyl peroxy groups which allow stepwise polymerisation of the hard and soft segments of the block copolymer.
  • the initiator CH-50-AL Peroxid-Chemie GmbH
  • Choice of reaction conditions is well within the skill of one in the art, once a suitable initiator has been chosen.
  • the initiator is preferably used in an amount of 0.005-0.1%) by weight of the block copolymer, with 0.01-0.05% by weight being particularly preferred, although it will be appreciated that the amount chosen is, again, well within the skill of one in the art. In particular, it is preferred that the amount should not be so much as to cause instant gelling of the mix, nor so low as to slow down polymerisation and to leave excess residual monomers. A preferred level of residual monomers is below 2000 ppm. It will also be appreciated that the amount of initiator will vary substantially, depending on such considerations as the initiator itself and the nature of the monomers.
  • a patch comprising a bioadhesive material and cosmetic of the present invention may be additionally used in combination with a drug, where necessary, to complement the cosmetic action.
  • Suitable drags are biologically active compounds or mixtures of compounds that have therapeutic, prophylactic or other beneficial pharmacological or physiological effects.
  • Transdermal patches and other dermal delivery means of the present invention may be suitably shaped to provide optimal delivery of the agent to the skin.
  • semi-circular patches may be suitable for delivery of cosmetics to a region on the face under the eye, where wrinkles may be present.
  • Other suitably shaped patches will be readily apparent to the skilled person.
  • the adhesive polymer for use in the invention may be prepared in any suitable manner as known in the art.
  • This will generally comprise the adhesive being prepared in a solvent and, prior to removal of the solvent, it is preferable to involve, as a final step, the polyamine.
  • This is mixed with the prepared adhesive solution and then applied to the tape or patch, or any other suitable application requiring such an adhesive material.
  • a further advantage of the present invention is that the cross-linking time is generally substantially reduced, so that manufacture is easier.
  • the solvent can be removed as known in the art.
  • the preferred adhesive strength of the bioadhesive material is such that, when applied to a tape or patch, the tape or patch can be applied to the skin and then removed without removing the stratum corneum layer of the skin surface.
  • an adhesive strength of about 30g/inch ( ⁇ 1.2g/mm) to about 300 g/inch ( ⁇ 12g mm), more preferably about 40g/inch ( ⁇ 1.6g/mm) to about 200 g/inch ( ⁇ 8g/mm) is preferred for the bioadhesive, although the skilled person will recognise appropriate strengths.
  • Materials with adhesive strength greater than about 300 g/inch ( ⁇ 8g/mm) are likely to cause skin irritation when the tape is removed, as the outer skin layer is concomitantly removed.
  • An adhesive compound suitable for use in the invention was prepared in a "2 + 1" synthesis.
  • the first step effectively provides the soft segment of the block copolymer, while the second step completes formation of the block copolymer.
  • cross-linking occurs, to form an insoluble product.
  • Step 1 After 24 hours, 45g methyl methacrylate and 300 ml of toluene were added to the mix of Step 1. The solution was then heated to 99°C in order to initiate the second stage polymerisation step, which was continued for 12 hours at 99°C
  • the polymer was transferred to a bottle for cooling.
  • the resulting solution contains the pre-crosslinked polymer, and can be stored for substantial periods.
  • the average molecular weight of the polymer produced in this way was estimated to be 358,000 Da by gel permeation chromatography.
  • This solution can be used, per se, but the solids content of the solution generally varies between about 30 and 50%. Accordingly, it is preferred to dry the solution, with heating, in order to obtain a first stage adhesive.
  • This adhesive generally corresponds to that of WO 99/02141, and, after the evaporation stage, already possesses a degree of cross-linking between the soft segments of the block copolymer.
  • This adhesive is then dissolved at a rate of 1.0 gper 2.0 g of a 2 : 5 v/v mixture of ethyl acetate and toluene.
  • step 2 containing l.Og of solid adhesive
  • plasticiser as specified [e.g. isopropyl myristate (IPM), l.Og]
  • cross-linker 1.0 ml of a solution of adipic acid diamine in 3 : 1 v/v methanol/water (0.5g in 100ml), unless otherwise specified] was mixed and coated onto substrate, generally a PET
  • polyethylene terephthalate film measuring 20 x 20 cm. This was then heated at 80°C for 20 minutes, covered with a PET release liner, and then allowed to stand at 40°C for 24 hours to complete cross-linking. The 20 x 20 PET film is then typically cut into strips measuring 10 x 2.5 cm.
  • Non- woven fabric (lOOg/m 2 ) was laminated onto the dried adhesive layer, and rectangular skin softening patches cut from the sheet (10 cm x 6 cm). These patches are suitable for night time application, during sleep, to the skin of the heel or elbow, for example, as skin softeners.
  • EXAMPLE 3
  • the patches were prepared as in Example 2, except that 100 mg of kojic acid was used in place of vitamin E acetate. Suitable patches are circular (diameter of 2.0 cm, for example) for application to the skin over birthmarks or age-spots, for example.
  • Patch Composition (% of total patch weight): Vitamin E acetate 22% Vitamin A palmitate 1%
  • Dermally attachable dispensing means comprising a substrate upon which is disposed an adhesive material, the adhesive material comprising a cross-linked, adhesive polymer and a plasticiser therefor, ketone groups in the adhesive being cross- linked by a polyamine cross-linking agent, the adhesive comprising plasticiser sufficient to reduce discomfort on dermal detachment, characterised in that the substance to be dispensed comprises a cosmetic agent.
  • Dispensing means according to claim 1 which is a patch or a tape.
  • Dispensing means according to claim 1 or 2 wherein the substrate is flexible and thin.
  • Dispensing means according to any preceding claim, wherein the substrate comprises a backing and a reservoir for the cosmetic agent.
  • Dispensing means according to any preceding claim wherein the cosmetic agent is loaded in the adhesive.
  • Dispensing means according to any preceding claim, wherein the adhesive is a contact adhesive.
  • Dispensing means wherein the cosmetic agent is one used to visibly reduce or reverse the effects of ageing upon the skin.
  • the cosmetic agent is selected from: vitamin C, vitamin D2, vitamin D3, vitamin A, vitamin E, pro-vitamin B5, natural and synthetic ceramides, alpha hydroxyacids, and retinoids; agents altering skin pigmentation; tyrosine; essential fatty acids; tocotrienols; herb extracts; phospholipids; squalene; urea; olive oil; lauric acid; isopropyl myristate; cetyl alcohol; essential oils including tea tree oil, peppermint oil, rosemary oil, avocado oil, almond oil, palm kernel oil, babassu oil, hemp seed oil, mango seed oil, brazil nut oil, grape seed oil, jojoba oil, sandlewood oil, carrot oil, peach kernel oil, wheat germ oil, macadamia nut oil, lavender oil and e
  • Dispensing means according to any preceding claim, wherein the adhesive has an adhesive strength such that, when after said means has been applied to the skin, removal can be effected without removing the stratum corneum layer of the skin surface.
  • a method of cosmetic treatment comprising applying a dispensing means or adhesive according to any preceding claim to hair or skin that it is desired to treat.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des dispositifs permettant de distribuer de façon avantageuse des agents cosmétiques, qui consistent en un matériau adhésif convenant en tant que bioadhésif composé d'un polymère adhésif et d'un plastifiant prévu à cet effet. L'adhésif, réticulé, est composé de groupes cétoniques réticulés par un agent de réticulation polyamine. De tels adhésifs présentent une bonne cohésion et une irritation dermique faible.
PCT/GB2001/003418 2000-07-27 2001-07-27 Bandes cosmetiques adhesives Ceased WO2002009653A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001272679A AU2001272679A1 (en) 2000-07-27 2001-07-27 Adhesive cosmetic patches

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0018467.1 2000-07-27
GB0018467A GB0018467D0 (en) 2000-07-27 2000-07-27 Adhesives

Publications (1)

Publication Number Publication Date
WO2002009653A1 true WO2002009653A1 (fr) 2002-02-07

Family

ID=9896456

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/003418 Ceased WO2002009653A1 (fr) 2000-07-27 2001-07-27 Bandes cosmetiques adhesives

Country Status (3)

Country Link
AU (1) AU2001272679A1 (fr)
GB (1) GB0018467D0 (fr)
WO (1) WO2002009653A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080089926A1 (en) * 2004-12-15 2008-04-17 Tomohiro Ishima External Patches Containing Etofenamate
US7985742B2 (en) 2002-04-24 2011-07-26 Archer Daniels Midland Company Synergistic compositions of polysaccharides as natural and biodegradable absorbent materials or super absorbents
JP2012219044A (ja) * 2011-04-06 2012-11-12 Nitto Denko Corp 貼付製剤
JP2012219045A (ja) * 2011-04-06 2012-11-12 Nitto Denko Corp 貼付剤および貼付製剤
EP2476414A4 (fr) * 2009-09-07 2013-05-22 Nipro Patch Co Ltd Préparation absorbable par voie transdermique
EP2575827A4 (fr) * 2009-06-05 2015-03-18 Fresenius Med Care Hldg Inc Sorbant d'urée
US9132000B2 (en) 1999-10-27 2015-09-15 Atritech Inc. Filter apparatus for ostium of left atrial appendage
US20190201298A1 (en) * 2018-01-03 2019-07-04 Rocketfuelabs, LLC Product and method for local cleansing, beautifying, promoting attractiveness or altering appearance of a subject
WO2020148642A1 (fr) * 2019-01-14 2020-07-23 Tompa Majcen Dominika Formulations contenant des composés actifs d'oxygène et dispositifs pour leur application
JP2021534118A (ja) * 2018-08-09 2021-12-09 花王株式会社 被膜を生成する方法
JP2021534136A (ja) * 2018-08-09 2021-12-09 花王株式会社 装着被膜の製造方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014822A1 (fr) * 1994-11-15 1996-05-23 Osmotics Corporation Procedes et compositions de soins pour la peau
WO1997043325A1 (fr) * 1996-05-10 1997-11-20 E.I. Du Pont De Nemours And Company Composes polymeres acryliques
WO1999026572A1 (fr) * 1997-11-25 1999-06-03 Theratech, Inc. Composition antioxydante de prevention et de traitement topique/transdermique des rides
WO2000044846A1 (fr) * 1999-01-29 2000-08-03 Strakan Limited Adhesifs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014822A1 (fr) * 1994-11-15 1996-05-23 Osmotics Corporation Procedes et compositions de soins pour la peau
WO1997043325A1 (fr) * 1996-05-10 1997-11-20 E.I. Du Pont De Nemours And Company Composes polymeres acryliques
WO1999026572A1 (fr) * 1997-11-25 1999-06-03 Theratech, Inc. Composition antioxydante de prevention et de traitement topique/transdermique des rides
WO2000044846A1 (fr) * 1999-01-29 2000-08-03 Strakan Limited Adhesifs

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10893926B2 (en) 1999-10-27 2021-01-19 Atritech, Inc. Filter apparatus for ostium of left atrial appendage
US9132000B2 (en) 1999-10-27 2015-09-15 Atritech Inc. Filter apparatus for ostium of left atrial appendage
US7985742B2 (en) 2002-04-24 2011-07-26 Archer Daniels Midland Company Synergistic compositions of polysaccharides as natural and biodegradable absorbent materials or super absorbents
US8747885B2 (en) * 2004-12-15 2014-06-10 Teikoku Seiyaku Co., Ltd. External patches containing etofenamate
US20140234396A1 (en) * 2004-12-15 2014-08-21 Teikoku Seiyaku Co., Ltd. External patches containing etofenamate
US20080089926A1 (en) * 2004-12-15 2008-04-17 Tomohiro Ishima External Patches Containing Etofenamate
EP2575827A4 (fr) * 2009-06-05 2015-03-18 Fresenius Med Care Hldg Inc Sorbant d'urée
EP2476414A4 (fr) * 2009-09-07 2013-05-22 Nipro Patch Co Ltd Préparation absorbable par voie transdermique
US9168232B2 (en) 2009-09-07 2015-10-27 Nipro Patch Co., Ltd. Transdermally absorbable preparation
JP2012219044A (ja) * 2011-04-06 2012-11-12 Nitto Denko Corp 貼付製剤
JP2012219045A (ja) * 2011-04-06 2012-11-12 Nitto Denko Corp 貼付剤および貼付製剤
US20190201298A1 (en) * 2018-01-03 2019-07-04 Rocketfuelabs, LLC Product and method for local cleansing, beautifying, promoting attractiveness or altering appearance of a subject
JP2021534118A (ja) * 2018-08-09 2021-12-09 花王株式会社 被膜を生成する方法
JP2021534136A (ja) * 2018-08-09 2021-12-09 花王株式会社 装着被膜の製造方法
US11759803B2 (en) 2018-08-09 2023-09-19 Kao Corporation Method for producing wearable coating
JP7495926B2 (ja) 2018-08-09 2024-06-05 花王株式会社 被膜を生成する方法
JP7495927B2 (ja) 2018-08-09 2024-06-05 花王株式会社 装着被膜の製造方法
WO2020148642A1 (fr) * 2019-01-14 2020-07-23 Tompa Majcen Dominika Formulations contenant des composés actifs d'oxygène et dispositifs pour leur application
AU2020210126B2 (en) * 2019-01-14 2021-10-07 Majcen, Dominika Tompa Formulations containing active oxygen compounds and devices for application thereof
US12268766B2 (en) 2019-01-14 2025-04-08 Dominika Tompa Majcen Formulations containing active oxygen compounds and devices for application thereof

Also Published As

Publication number Publication date
GB0018467D0 (en) 2000-09-13
AU2001272679A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
EP1165716B1 (fr) Adhesifs
CA2217888C (fr) Utilisation de la triacetine comme stimulation de penetration transdermique
AU718096B2 (en) Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
JP5600737B2 (ja) 水溶性感圧接着剤
JP2700835B2 (ja) アクリル系ゲル材およびアクリル系ゲル製剤
EP2258407A2 (fr) Compositions transdermiques contenant des médicaments de faible poids moléculaire liquides à température ambiante
JP3576608B2 (ja) 貼付剤および貼付製剤
TW577750B (en) Patch containing isosorbide dinitrate
CN1509164A (zh) 释放化妆品和药物的体系
WO2004047820A1 (fr) Cataplasme chaud
EP1318843B1 (fr) Adhesif non reactif, utile dans des systemes d'apport transdermique de medicaments
KR20080014461A (ko) 경피투여형 화장료 패치
WO2003013482A1 (fr) Administration transdermique d'antagonistes de 5-ht3
JPWO2000048580A1 (ja) シート状貼付剤
CA2487123C (fr) Timbre contenant du fentanyl
JP3014188B2 (ja) アクリル系ゲル材およびアクリル系ゲル製剤
JPH11209271A (ja) 経皮吸収製剤
JPH0565224A (ja) ゲル材およびこれを用いた治療用ゲル製剤
JP2000026285A (ja) 貼付剤
US20020051796A1 (en) Solution of a polymer of the polyacrylic and/or polyvinylic type associated with a filler and a keratolytic agent, and a cosmetic device for cleaning and care of the skin
JP4293478B2 (ja) 貼付剤
JP2003081815A (ja) 皮膚処理用製剤
JPH11209270A (ja) 経皮吸収製剤
WO2002009676A1 (fr) Pansements adhesifs pour le traitement et la prophylaxie des cicatrices
JP2009102351A (ja) 貼付剤

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP